GlassScriptPhysician profile
Belur J Patel
NPI 1891756680
$5,454.87
in general payments reported to CMS, 2019-2025
23 companies · $984 in 2025
The $984 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $877 · 2020: $213 · 2021: $492 · 2022: $860 · 2023: $605 · 2024: $1,424 · 2025: $984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,376 · Travel and Lodging: $552 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,375.93 |
| Travel and Lodging | $552.01 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,473.41 | 2019-2025 | Aquabeam System |
| Boston Scientific Corporation | $435.13 | 2019-2024 | Rezum Generator |
| Astellas Pharma US INC | $403.50 | 2022-2025 | Xtandi, Myrbetriq |
| Calyxo, INC. | $361.80 | 2025 | Cvac Aspiration System |
| Janssen Biotech, INC. | $312.00 | 2022-2024 | Erleada |
| Medtronic, INC. | $302.05 | 2022-2025 | Ligasure |
| Olympus America INC. | $271.41 | 2022-2024 | Soltive, Itind System |
| Metuchen Pharmaceuticals | $259.19 | 2019 | |
| Cook Medical LLC | $211.22 | 2019-2024 | Ncircle |
| Coloplast Corp | $188.45 | 2023-2024 | Titan |
| Sumitomo Pharma America, INC. | $173.18 | 2023-2025 | Gemtesa |
| Abbvie INC. | $146.85 | 2019 | |
| Palette Life Sciences, INC. | $142.86 | 2022 | |
| Uroviu Corporation | $142.45 | 2023 | Uro-G Flexible Cystoscope |
| Pfizer INC. | $133.73 | 2020-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $118.51 | 2021 | |
| Photocure INC | $97.48 | 2019 | |
| Myriad Genetic Laboratories, INC. | $86.06 | 2021 | |
| Antares Pharma, INC. | $59.94 | 2024-2025 | Xyosted |
| Tolmar, INC. | $55.27 | 2025 | Eligard, Jatenzo |
| 180 Medical, INC. | $41.20 | 2024-2025 | Gentlecath |
| Healthtronics Stone Solutions, LLC | $23.39 | 2019 | |
| Philips North America LLC | $15.79 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Belur Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.